article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

This allows patients to complete the whole treatment process, from drug preparation and drug administration to treatment monitoring, side effect reporting, and communication, with one click on their device and smartphone.

article thumbnail

Top-10 ways for Pharma to leverage AI according to…AI

Impetus Digital

In theory, this will allow for highly tailored, personalized therapy plans with superior efficacy and minimal side effects. Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology.

Pharma 92
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5% For example, non-branded generics account for more than 40% of the total US pharmaceutical market in the United States and more than 50% in the United Kingdom.

article thumbnail

Precision Medicine Needs an Overhaul

PM360

As cost constraints and care rationing under the transition to corporatist “value-based” care, any reduction in cost, misdiagnosis, non-targeted treatment, and unnecessary side effects must shift focus of care from reaction to prediction, and from Rx cycling to prevention.

article thumbnail

Top 5 Emerging Trends in Pharma Industry

Medico Reach

With the use of trailblazing digital platforms, cost-effective technologies, big data analytics, blockchain, and artificial intelligence (AI), the landscape is undergoing a massive transition. The global pharmaceutical manufacturing market stood at USD 405.52 billion in 2020 and will project growth of USD 4.18

Pharma 52
article thumbnail

How could tariffs impact the pharmaceutical industry?

European Pharmaceutical Review

4 Reshoring and diversification of pharmaceutical supply chains In response to potential tariffs, pharmaceutical manufacturers could consider shifting production closer to domestic markets to reduce exposure. Trump’s Tariffs’ Possible Side Effects Include Making Pain Relievers And Antibiotics More Expensive.